High-Grade Hyperplasia Automated Detection

About Ikonisys

Founded in 2003 and headquartered in New Haven, USA, Ikonisys has established itself as a premier provider of automated FISH technology for oncology diagnostics. The company's core platform integrates automated microscopy, image analysis, and multiplexed assays to detect genetic alterations and rare circulating tumor cells with high sensitivity and specificity. By automating manual FISH processes, Ikonisys aims to increase lab throughput, reduce human error, and support the growing field of precision medicine. Its solutions target pathology labs seeking to standardize and scale complex genetic testing.

Therapeutic Areas